Affiliation:
1. Associate Professor, General Medicine, Pushpagiri Institute of medical sciences and research center
2. Junior resident, General Medicine, Pushpagiri Institute of medical sciences and research center.
3. Assistant Professor, General Medicine, Pushpagiri Institute of medical sciences and research center
Abstract
Hypercalcemia in adults arises from a myriad of underlying causes. Etiology of hypercalcemia varies from causes like
Vitamin D toxicity to hyperparathyroidism, hyperthyroidism, chronic kidney disease, granulomatous diseases, and
malignant diseases .Though not an uncommon metabolic problem, hypercalcemia can easily be missed due to the diverse clinical presentations.
Primary hyperparathyroidism and malignancy are the most common causes, accounting for 90% of the cases. Clinical manifestation varies
depending on the ionized calcium levels. Symptoms manifest when calcium levels exceed 12 mg/dl. We report four different cases that illustrate
the need for a focused workup of hypercalcemia. Routine hypercalcemia workup includes serum Parathormone (PTH), Vitamin D, ionized
calcium, phosphorus, magnesium, alkaline phosphatase levels, renal functions, and urinary calcium-creatinine ratio. Prognosis depends on the
cause of hypercalcemia. The clinical diagnosis needs a high index of suspicion. Denitive management requires focused workup for etiological
diagnosis and treatment of underlying cause. Treatment for hypercalcemia is required in all symptomatic patients or if the calcium level exceeds
more than 15 mg/dL, even if asymptomatic. Immediate management includes restoring intravascular volume and promoting diuresis. Calcitonin,
Bisphosphonates and steroids play a role in medical management. For patient's refractory to medical treatment, hemodialysis is required.
Reference13 articles.
1. Catalano A, Chilà D, Bellone F, et al.: Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing?. J ClinTransl Endocrinol. 2018, 13:9-13. 10.1016/j.jcte.2018.05.004
2. Assadi F: Hypercalcemia: An Evidence‐Based Approach to Clinical Cases. Iran J Kidney Dis. 2009, 3:71-9.
3. Bilezikian JP: Primary Hyperparathyroidism. J Clin Endocrinol Metab. 2018, 103:3993-4004. 10.1210/jc.2018-01225
4. Carrick AI, Costner HB: Rapid Fire: Hypercalcemia. Emerg Med Clin North Am. 2018, 36:549-555. 10.1016/j.emc.2018.04.008
5. Bartalena L: Graves’ Disease: Complications. [Updated 2018 Feb 20]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. 2000.